← Back to Search

Physical Performance Assessment for Safe Return to Sport (CASE Trial)

N/A
Recruiting
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1.5 hours
Awards & highlights

CASE Trial Summary

This trial assesses an athlete's physical performance in response to dynamic exertion, in order to identify system impairments that may keep them from safely returning to their sport.

Who is the study for?
This trial is for athletes aged 10-22 who've had a concussion but are symptom-free at rest and cleared to play within the last 30 days. They must have played organized sports in the past year. It's not for those with severe brain injuries, cardiopulmonary conditions, certain mental health diagnoses, more than three concussions, diabetes, uncontrolled asthma, pregnancy or current COVID-19 symptoms.Check my eligibility
What is being tested?
The CASE test measures an athlete's physical response during sport-specific activities to help decide if they're ready to return to sports after a concussion. It looks at physiological and symptomatic responses across various body positions typical of different sports like soccer and basketball.See study design
What are the potential side effects?
Since CASE is an exercise-based assessment rather than a drug treatment, there aren't traditional side effects. However, it may provoke symptoms in recovering athletes which can inform healthcare professionals about their readiness to resume sporting activities.

CASE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1.5 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1.5 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood pressure (mmHg)
Heart rate (bpm)
Heart rate reserve (peak-rest), beats/min-1
+4 more
Secondary outcome measures
Modified Post-Concussion Symptom Scale (PCSS) (0-6)

CASE Trial Design

1Treatment groups
Experimental Treatment
Group I: CASEExperimental Treatment1 Intervention
In this prospective study the investigators aim to quantify participants' responses to physical activity. Participants will be asked to engage in physical activity, to identify any provocation of symptoms in adolescents ranging from ages 10 to 22 years. Responses to physical activity will be measured through physiologic markers (e.g., blood pressure, heart rate, oxygen saturation, rate of perceived exertion, dyspnea). Additionally, participants will be monitored for any changes in symptoms that occur during or after physical activity as measured by the modified PCSS symptom inventory.

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
200 Previous Clinical Trials
203,296 Total Patients Enrolled
Sports AcademyUNKNOWN
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

CASE Clinical Trial Eligibility Overview. Trial Name: NCT05013307 — N/A
Return to Sport Research Study Groups: CASE
Return to Sport Clinical Trial 2023: CASE Highlights & Side Effects. Trial Name: NCT05013307 — N/A
CASE 2023 Treatment Timeline for Medical Study. Trial Name: NCT05013307 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What kind of individual is most suitable for this trial?

"For this experiment, 125 individuals aged between 10 and 22 will be required to demonstrate their return to sport within the last year. To qualify for participation in the study applicants must meet a set of criteria: from 10-22 years old with documentation that they have been involved in competitive sports activities over the past 12 months."

Answered by AI

Are there any remaining slots for patients to join this clinical trial?

"As suggested by the information displayed on clinicaltrials.gov, this medical trial is currently recruiting patients. The study was first advertised on August 7th 2021 and has been recently updated as of February 28th 2022."

Answered by AI

What is the participant intake for this research endeavor?

"Affirmative. Clinicaltrials.gov hosts data confirming this medical study, which was published on August 7th 2021, is actively enrolling participants. The trial has allocated 125 spots across a single facility to date."

Answered by AI

Does the current clinical trial accept elderly individuals as participants?

"Candidates must meet the eligibility guidelines to be considered for this trial; these include being aged between 10 and 22."

Answered by AI
~34 spots leftby Apr 2025